Fig 1: Diagnostic efficacy and value of LAMA2, MLL4, PLXDC2, CD14, CLU, CD99 and SAA2 in healthy and pre-diabetic sera of human origin. After immunoblotting analysis, diagnosis efficacy was analyzed using a ROC curve. Sensitivity, specificity, and accuracy were evaluated for diagnostic value.
Fig 2: Immunoblotting analysis of LAMA2, MLL4, PLXDC2, CD14, CLU, CD99, and SAA2 in healthy and pre-diabetic sera of human origin. Serum samples of healthy and pre-diabetic subjects were collected and then lysed with lysis buffer. After centrifugation, total lysates were prepared for immunoblotting analysis with the antibodies as indicated. Transferrin (TF) was used as an internal control of human sera.
Supplier Page from CUSABIO Technology LLC for Human Laminin subunit alpha-2(LAMA2) ELISA Kit